Steno Diabetes Center Copenhagen: Diabetes Mellitus, Type 1 trials

The registry lists 49 Diabetes Mellitus, Type 1 studies with Steno Diabetes Center Copenhagen as lead sponsor. 10 are open to participants now and 1 have results posted.

Phase 2 4Phase 3 3Phase 4 7No phase 36(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Exploring Skin Barrier Function, Recurrence of Diabetes Device-Related Contact Dermatitis, and Evaluation of Hydrocolloid and Silicone-Based Patches for Its Prevention in Children and Adolescents With Type 1 DiabetesRecruitingNCT07767461Not applicable
• Changing Outpatient Diabetes Care With Remote-Patient-Monitoring: A Real World Evidence Study With Pre-Post ComparisonRecruitingNCT07617519
• Steno780G Follow-up StudyNot yet recruitingNCT07474155
• The Postprandial Hypo-Avoid StudyRecruitingNCT07427251Phase 4
• The Steno Opti-Bolus-Timing StudiesNot yet recruitingNCT07021690Not applicable
• A Trial of Three- and Seven-days Insulin Infusions SetRecruitingNCT06532461Not applicable
• Automated Insulin Delivery for Type 1 Diabetes - Beyond Glucose MetricsRecruitingNCT06469593Not applicable
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxiaNot yet recruitingNCT06147232Phase 2
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 DiabetesRecruitingNCT06082063Phase 3
• Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 DiabetesRecruitingNCT05159856
• Glucagon and Advanced HCL System to Prevent Exercise-Induced Hypoglycaemia in People With Type 1 DiabetesCompletedNCT05379686Not applicableResults posted
• Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal DiseaseCompletedNCT06330194Not applicable
• Four-Week SkinSiteStudy in Type 1 DiabetesCompletedNCT06177054Not applicable
• The Importance of Sleep for Diabetes Associated Tasks and OutcomesCompletedNCT05762783
• The Effects of Different Exercise Modalities in Adolescents With Type 1 Diabetes Using AID SystemsStatus unknownNCT05619198Not applicable
• The Impact of Macronutrient Composition on Glucose Dynamics in Persons With Type 1 DiabetesCompletedNCT05268705Not applicable
• The SMART A Exercise Study :''The SMART Study''CompletedNCT05134025Not applicable
• Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 DiabetesCompletedNCT05076292Not applicable
• Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 DiabetesCompletedNCT04949867Phase 4
• The Steno 780G StudyCompletedNCT04914910Not applicable
• Cardiovascular Effects of Rapidly Declining Plasma Glucose in Patients With Type 1 DiabetesCompletedNCT04800536Not applicable
• Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 DiabetesCompletedNCT04764968Phase 2
• Cardiovascular Effects of Exercise-related Hypoglycaemia in Patients With Type 1 Diabetes (Hypo Heart Exercise)CompletedNCT04650646Not applicable
• Effects of Probiotics and Fibers on Albuminuria in Persons With Type 1 DiabetesCompletedNCT04635670Not applicable
• The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.CompletedNCT04472962Not applicable
• Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 DiabetesCompletedNCT04449692Phase 2
• Glycaemia and Cardiac Function in Patients With COVID-19CompletedNCT04410718
• Steno Tech Explore: A Study of Insulin Pump Users With Type 1 DiabetesCompletedNCT04311164
• Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 DiabetesCompletedNCT04193566Phase 4
• The Effect of Rapid and Slow Glucose Fall on the Subsequent Glucose Production in People With Type 1 DiabetesCompletedNCT04098549Not applicable
• Effects of Frequency and Duration of Exercise in People With Type 1 Diabetes A Randomized Crossover StudyCompletedNCT04089462Not applicable
• Effect of Butyrate on Inflammation and Albuminuria in Patients With Albuminuria, Type 1 Diabetes and Intestinal InflammationStatus unknownNCT04073927Not applicable
• Dual-hormone Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT04053712Phase 4
• Hypoglycaemia and Cardiac Arrhythmias in Type 1 DiabetesCompletedNCT04011683
• Hypoglycemia and Cardiac Arrhythmias in Type 1 DiabetesCompletedNCT03956173
• The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 DiabetesCompletedNCT03734718Not applicable
• GABA Treatment in Subjects With Type 1 DiabetesStatus unknownNCT03721991Not applicable
• Optimizing Metabolic Control in Type 1 Diabetes - The Automatic Bolus Calculator Flash StudyCompletedNCT03682237Not applicable
• The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 DiabetesCompletedNCT03623113Not applicable
• Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 DiabetesCompletedNCT03556098Not applicable
• Advanced Carbohydrate Counting and Automated Bolus CalculationCompletedNCT02084498Not applicable
• Liraglutide in Type 1 DiabetesCompletedNCT01612468Phase 4
• Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic NephropathyCompletedNCT01521910Not applicable
• Low Glycemic Index Diet in Patients With Type 1 DiabetesCompletedNCT01184703Phase 3
• Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 DiabetesCompletedNCT01171248
• Anti-Interleukin-1 in Diabetes ActionCompletedNCT00711503Phase 2/3
• Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone TherapyCompletedNCT00335413Phase 4
• Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
• Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietCompletedNCT00118937Phase 4